 |
 |
 |
 |
 |
 |
 |
The safety of ATOPICA® (Cyclosporine capsules, USP) MODIFIED has been extensively tested in laboratory trials and under field conditions.12
The results of these studies confirm that ATOPICA is safe and well-tolerated when given to dogs at the labeled rate of 5 mg/kg/day. Most common adverse drug effects, when present, either spontaneously resolve or are reversed after discontinuation of the drug.
Download the full results of the study.
The U.S. clinical trial confirmed the efficacy of ATOPICA for the control of canine atopic dermatitis and provide visual evidence of the effect of 90 days of cyclosporine therapy in a chronic case.
Multiple studies have also shown cyclosporine to be effective for control of atopic dermatitis in dogs:
